drugset / Trial / NCT00561717

A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis

NCT00561717

Phase 4 Completed 70 enrolled Bayer Kingston Health Sciences Centre · collab
RandomizedCrossoverTriple-blindTreatment

Summary

Finding out how fast azelastine nasal spray works in subjects with hay fever.

Timeline

Start
2007-10
Primary completion
2007-12
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Azelastine Small molecule Intranasal
Comparator Cetirizine Other / unclassified 10 mg Oral
Comparator Loratadine Small molecule 10 mg Oral